돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 449486생성일: 2026년 10월 24일

Diisopropylethylamine → methyl (2S)-2-({[2-amino-4-(4-methylpiperazin-1-yl)quinazolin-7-yl]carbonyl}amino)-3-biphenyl-4-ylpropanoate

https://huagongshe.com/ko/reaction/449486

반응식

참여 물질

역할이름HCID투입량
반응물DiisopropylethylamineHCID 81531—
반응물Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 9886157—
반응물(S)-Methyl 3-([1,1'-biphenyl]-4-yl)-2-aminopropanoateHCID 15714801—
반응물2-Amino-4-(4-methylpiperazin-1-yl)quinazoline-7-carboxylic acidHCID 59496649—
용매DimethylformamideHCID 6228—
생성물methyl (2S)-2-({[2-amino-4-(4-methylpiperazin-1-yl)quinazolin-7-yl]carbonyl}amino)-3-biphenyl-4-ylpropanoateHCID 4977903813.6%

반응 단계

N,N,N′,N′-Tetramethyl-O-(7-azabenzotriazol-1-yl)uronium hexafluorophosphate (42 mg, 0.11 mmol) was added to a solution of 2-amino-4-(4-methylpiperazin-1-yl)quinazoline-7-carboxylic acid (20 mg, 0.07 mmol) in N,N-dimethylformamide (2 mL) and N,N-diisopropylethylamine (24 uL, 0.14 mmol). The methyl (2S)-2-amino-3-biphenyl-4-ylpropanoate (36 mg, 0.14 mmol) was added. The reaction was stirred for 2 h. at r.t., and was purified by RP-HPLC (pH=2) to afford the desired product (5 mg, 10%) as a white solid TFA salt. Analytical LCMS (M+H)+: m/z=525.1.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08481732B2
출처 데이터셋uspto-grants-2013_07
ORD IDord-51148be0f5ee4680ae5583e36fb1948b
출처 메모uspto-grants-2013_07